Safety and danger considerations of novel treatments for atopic dermatitis in context of primary cutaneous lymphomas
K Kołkowski, M Trzeciak… - International Journal of …, 2021 - mdpi.com
The impact of new and emerging therapies on the microenvironment of primary cutaneous
lymphomas (PCLs) has been recently raised in the literature. Concomitantly, novel …
lymphomas (PCLs) has been recently raised in the literature. Concomitantly, novel …
Pimecrolimus for the treatment of atopic dermatitis in infants: an Asian perspective
CY Chu, TC Yao, IH Shih, CY Yang, CL Chin… - Dermatology and …, 2023 - Springer
Atopic dermatitis (AD) is a common chronic, multisystem inflammatory skin disease in
pediatric patients. There has been an increase in the incidence of AD in the pediatric …
pediatric patients. There has been an increase in the incidence of AD in the pediatric …
Study on the antipruritic mechanism of Zanthoxylum bungeanum and Zanthoxylum schinifolium volatile oil on chronic eczema based on H1R and PAR-2 mediated …
XL Zhou, L Le Chen, JF Wang - Allergologia et Immunopathologia, 2022 - all-imm.com
Objective: To observe the antipruritic effect and mechanism of the volatile oil of Zanthoxylum
bungeanum and Zanthoxylum schinifolium on chronic eczema to provide data support for …
bungeanum and Zanthoxylum schinifolium on chronic eczema to provide data support for …
Safety and efficacy of Pimecrolimus in atopic dermatitis among Chinese infants: A sub-group analysis of a five-year open-label study
X Dou, L Liu, X Zhu, W Wen, C Ni, Y Zhao… - Journal of …, 2023 - Taylor & Francis
Introduction Atopic dermatitis (AD) exhibits difference in immune polarization between
Caucasians and Asian races due to which an evaluation of the efficacy and safety of …
Caucasians and Asian races due to which an evaluation of the efficacy and safety of …
Clinically meaningful improvements in cutaneous lesions and quality of life measures in patients with atopic dermatitis with greater pruritus reductions after treatment …
K Kabashima, T Matsumura, Y Hayakawa… - Journal of …, 2023 - Taylor & Francis
Abstract Background Data from the Japanese phase 3 Nemolizumab-JP01 study (JapicCTI-
173740) found that nemolizumab in combination with topical treatments reduced pruritus …
173740) found that nemolizumab in combination with topical treatments reduced pruritus …
Efficacy and anti-inflammatory properties of low-molecular-weight fucoidan in patients with atopic dermatitis: a randomized double-blinded placebo-controlled trial
HL Shih, PH Wang, IH Shih, S Hu, JR Lin… - … Journal of Food …, 2024 - Taylor & Francis
Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disease. Fucoidans are
reportedly effective in treating AD; however, their clinical efficacy requires further …
reportedly effective in treating AD; however, their clinical efficacy requires further …
Causal association between atopic eczema and inflammatory bowel disease: A two‐sample bidirectional Mendelian randomization study of the East Asian population
L Wang, Y Wang, XE Wang, B Chen… - The Journal of …, 2023 - Wiley Online Library
Observation studies have postulated that atopic eczema is associated with a risk of
inflammatory bowel disease in the East Asian population; however, this association does not …
inflammatory bowel disease in the East Asian population; however, this association does not …
Special Considerations of Atopic Dermatitis in Skin of Color
A Marcelletti, DM Shan, W Abdi, K Lovell… - Management of Atopic …, 2024 - Springer
Atopic dermatitis (AD) is a chronic inflammatory skin condition with heterogeneous
presentations and prevalence across different skin tones. In this chapter, AD is explored …
presentations and prevalence across different skin tones. In this chapter, AD is explored …
Cost‐effectiveness analysis of abrocitinib compared with standard of care in adult moderate‐to‐severe atopic dermatitis in Japan
A Tanaka, A Yuasa, K Kamei, M Nagano… - The Journal of …, 2024 - Wiley Online Library
Atopic dermatitis (AD) is a chronic inflammatory skin disease with a significant clinical,
economic, and human burden. The JAK1 Atopic Dermatitis Efficacy and Safety (JADE) …
economic, and human burden. The JAK1 Atopic Dermatitis Efficacy and Safety (JADE) …
Associations of demographics, aggravating factors, comorbidities, and treatments with atopic dermatitis severity in China: A national cross-sectional study
J Zhao, Z Zhang, H Chen, X Dou, Z Zhao… - Chinese Medical …, 2024 - journals.lww.com
Background: Atopic dermatitis (AD) is a chronic inflammatory skin disorder impacting
populations worldwide, although its clinical characteristics and patient demographics remain …
populations worldwide, although its clinical characteristics and patient demographics remain …